Title : Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.

Pub. Date : 2010 Sep 1

PMID : 20137866






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We conducted a Phase I study of vandetanib, an inhibitor of vascular endothelial growth factor receptor 2 and epidermal growth factor receptor, in patients with newly diagnosed GBM combined with RT and temozolomide (TMZ). vandetanib epidermal growth factor receptor Homo sapiens